KNSA
$83.17+4.64%
Kiniksa Pharmaceuticals International plcStock · HealthcareRussell 2000 · 0.08% of IWMNasdaq Composite · 0.008% of ONEQUS Stock Market · 0.004% of VTIRussell 3000 · 0.004% of IWV
Kiniksa Pharmaceuticals International plc monthly returns
Kiniksa Pharmaceuticals International plc has averaged 2.33% per month, positive in 54% of months. Month-by-month returns for Kiniksa Pharmaceuticals International plc (KNSA) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+2.3%
94 months
Best month
+51.1%
Nov 2019
Worst month
-37.7%
Jan 2019
Positive months
54%
of all months
Kiniksa Pharmaceuticals International plc monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | +11.5% | |
| Sep 2026 | -5.1% | |
| Aug 2026 | +5.8% | |
| Jul 2026 | +16.2% | |
| Jun 2026 | +32.2% | |
| May 2026 | -10.0% | |
| Apr 2026 | +11.7% | |
| Mar 2026 | +8.2% | |
| Feb 2026 | +1.3% | |
| Jan 2026 | +6.5% | |
| Dec 2025 | -3.0% | |
| Nov 2025 | +14.9% | |
| Oct 2025 | -4.7% | |
| Sep 2025 | +15.9% | |
| Aug 2025 | +10.7% | |
| Jul 2025 | +9.4% | |
| Jun 2025 | +1.1% | |
| May 2025 | +1.4% | |
| Apr 2025 | +21.4% | |
| Mar 2025 | +9.5% | |
| Feb 2025 | +3.5% | |
| Jan 2025 | -0.9% | |
| Dec 2024 | -10.4% | |
| Nov 2024 | -2.3% | |
| Oct 2024 | -9.6% | |
| Sep 2024 | -6.5% | |
| Aug 2024 | +0.5% | |
| Jul 2024 | +42.5% | |
| Jun 2024 | -1.8% | |
| May 2024 | +1.5% | |
| Apr 2024 | -5.1% | |
| Mar 2024 | -6.7% | |
| Feb 2024 | +19.9% | |
| Jan 2024 | +0.5% | |
| Dec 2023 | +8.5% | |
| Nov 2023 | +6.0% | |
| Oct 2023 | -12.2% | |
| Sep 2023 | +0.8% | |
| Aug 2023 | -8.5% | |
| Jul 2023 | +33.8% | |
| Jun 2023 | +1.6% | |
| May 2023 | +28.9% | |
| Apr 2023 | -0.1% | |
| Mar 2023 | -16.3% | |
| Feb 2023 | -11.1% | |
| Jan 2023 | -3.5% | |
| Dec 2022 | -11.0% | |
| Nov 2022 | +47.4% | |
| Oct 2022 | -11.1% | |
| Sep 2022 | +9.6% | |
| Aug 2022 | +18.3% | |
| Jul 2022 | +2.3% | |
| Jun 2022 | +26.5% | |
| May 2022 | -17.9% | |
| Apr 2022 | -6.1% | |
| Mar 2022 | -2.9% | |
| Feb 2022 | -8.8% | |
| Jan 2022 | -4.6% | |
| Dec 2021 | +1.3% | |
| Nov 2021 | +11.8% | |
| Oct 2021 | -8.8% | |
| Sep 2021 | -9.5% | |
| Aug 2021 | -17.9% | |
| Jul 2021 | +10.1% | |
| Jun 2021 | +2.2% | |
| May 2021 | -17.2% | |
| Apr 2021 | -11.1% | |
| Mar 2021 | -10.0% | |
| Feb 2021 | +4.5% | |
| Jan 2021 | +11.4% | |
| Dec 2020 | -5.3% | |
| Nov 2020 | +19.2% | |
| Oct 2020 | +2.2% | |
| Sep 2020 | -13.3% | |
| Aug 2020 | -9.5% | |
| Jul 2020 | -23.4% | |
| Jun 2020 | +22.1% | |
| May 2020 | +4.6% | |
| Apr 2020 | +28.9% | |
| Mar 2020 | -16.1% | |
| Feb 2020 | +25.5% | |
| Jan 2020 | +33.0% | |
| Dec 2019 | +3.8% | |
| Nov 2019 | +51.1% | |
| Oct 2019 | -17.2% | |
| Sep 2019 | -3.6% | |
| Aug 2019 | -25.2% | |
| Jul 2019 | -12.9% | |
| Jun 2019 | -11.2% | |
| May 2019 | +2.1% | |
| Apr 2019 | -17.3% | |
| Mar 2019 | +0.6% | |
| Feb 2019 | +2.6% | |
| Jan 2019 | -37.7% | |
| Dec 2018 | +38.9% | |
| Nov 2018 | +6.2% | |
| Oct 2018 | -25.3% | |
| Sep 2018 | +15.7% | |
| Aug 2018 | +57.5% | |
| Jul 2018 | -19.4% | |
| Jun 2018 | +1.4% |
Monthly total return (since Nov 2021)#
-40%-20%0%20%40%
Nov 2021+12%
Dec 2021+1.3%
Jan 2022-4.6%2022
Feb 2022-8.8%
Mar 2022-2.9%
Apr 2022-6.1%
May 2022-18%
Jun 2022+27%
Jul 2022+2.3%
Aug 2022+18%
Sep 2022+9.6%
Oct 2022-11%
Nov 2022+47%
Dec 2022-11%
Jan 2023-3.5%2023
Feb 2023-11%
Mar 2023-16%
Apr 2023-0.09%
May 2023+29%
Jun 2023+1.6%
Jul 2023+34%
Aug 2023-8.5%
Sep 2023+0.81%
Oct 2023-12%
Nov 2023+6.0%
Dec 2023+8.5%
Jan 2024+0.51%2024
Feb 2024+20%
Mar 2024-6.7%
Apr 2024-5.1%
May 2024+1.5%
Jun 2024-1.8%
Jul 2024+42%
Aug 2024+0.53%
Sep 2024-6.5%
Oct 2024-9.6%
Nov 2024-2.3%
Dec 2024-10%
Jan 2025-0.91%2025
Feb 2025+3.5%
Mar 2025+9.5%
Apr 2025+21%
May 2025+1.4%
Jun 2025+1.1%
Jul 2025+9.4%
Aug 2025+11%
Sep 2025+16%
Oct 2025-4.7%
Nov 2025+15%
Dec 2025-3.0%
Jan 2026+6.5%2026
Feb 2026+1.3%
Mar 2026+8.2%
Apr 2026+12%
May 2026-10%
Jun 2026+32%
Jul 2026+16%
Aug 2026+5.8%
Sep 2026-5.1%
Oct 2026+11%
Kiniksa Pharmaceuticals International plc returns by calendar month#
Every month of every year since 2019, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: +11.47% — 1st of 8 Octobers since 2019 at the last close; the average October returned -8.8%.
| Month | −55%0+55% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +0.6% | -0.2% | 50% | +33.0% 2020 | -37.7% 2019 | |
| Feb | +4.7% | +3.0% | 75% | +25.5% 2020 | -11.1% 2023 | |
| Mar | -4.2% | -4.8% | 38% | +9.5% 2025 | -16.3% 2023 | |
| Apr | +2.8% | -2.6% | 38% | +28.9% 2020 | -17.3% 2019 | |
| May | -0.8% | +1.5% | 63% | +28.9% 2023 | -17.9% 2022 | |
| Jun | +9.1% | +1.9% | 75% | +32.2% 2026 | -11.2% 2019 | |
| Jul | +9.7% | +9.7% | 75% | +42.5% 2024 | -23.4% 2020 | |
| Aug | -3.2% | -4.0% | 50% | +18.3% 2022 | -25.2% 2019 | |
| Sep | -1.5% | -4.4% | 38% | +15.9% 2025 | -13.3% 2020 | |
| Oct | -8.8% | -9.6% | 14% | +2.2% 2020 | -17.2% 2019 | |
| Nov | +21.2% | +14.9% | 86% | +51.1% 2019 | -2.3% 2024 | |
| Dec | -2.3% | -3.0% | 43% | +8.5% 2023 | -11.0% 2022 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from KNSA's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Kiniksa Pharmaceuticals International plc's average monthly return?
- Kiniksa Pharmaceuticals International plc (KNSA) has averaged about 2.33% per month, positive in roughly 54% of months. The best month was Nov 2019 (+51.1%) and the worst was Jan 2019 (-37.7%).
More on Kiniksa Pharmaceuticals International plc
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100